Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...Johnson & Johnson has offered an improved $6.5bn settlement to tens of thousands of plaintiffs claiming that its talcum powder products caused ovarian cancer, in its latest attempt to draw a line under the...
...Johnson & Johnson had received scorn for executing the so-called Texas Two-Step bankruptcy strategy. The healthcare titan was facing thousands of claims about allegedly carcinogenic talcum powder....
...Johnson & Johnson will ask tens of thousands of plaintiffs claiming the drugmaker’s baby powder and talc-based products led to ovarian cancer to vote in favour of an improved $6.5bn settlement deal, in its...
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...John Lytle, Tabula’s chief executive who will continue in the role, said the plan was to launch a wide range of both active bond and equity ETFs in Europe, some based on Janus’s existing US investment products...
...Armour said some ETF issuers were launching products specifically because they work well as building blocks in model portfolios, encouraging their take-up....
...This includes both active and passive strategies, and may therefore include products tracking a Paris-aligned or climate transition benchmark, provided that they meet the criteria.”...
...These tightly constrained “shy active” products “offer a less punchy entry point for investors and allow for greater scalability, whereas the low fees make them more competitive against both traditional...
...The UK regulator said last week it “continued to believe that crypto ETNs and crypto derivatives are ill-suited for retail consumers due to the harm they pose”....
...Referring purely to US-listed, rather than global, ETF flows, he added “utilities now lead outflows in 2024, while consumer staples and healthcare have the most outflows over the past year”....
...The London-listed consumer goods company’s share price dropped to its lowest level in a decade on Friday as investors absorbed the news....
...Concentration “is as high as it has been, certainly for the past three decades, potentially even longer”, said Dimitris Melas, head of index research and product development at MSCI....
...He added, however, that the group was looking at whether there were linked news and AI products for professionals that could exist behind a paywall....
...Just when you thought its shares couldn’t go higher, consumer review website Trustpilot swung to a profit in the year ending December 31....
...Some have speculated that Reckitt has been trying to sell Mead Johnson, the infant formula business it acquired for $17bn in 2017....
...SELL: Asos (ASC) The journey to a leaner and more agile business could be a long one, writes Jennifer Johnson....
...“Unless the case can be made that crypto has meaningfully changed in the last three years, it’s hard to see why the FCA would authorise them,” Prosser said, while the FCA’s Consumer Duty rules requiring...
...Financials, consumer staples and energy are favoured in value strategies,” he said....
...“These products solve a problem. You want to get income and risk mitigation yet still need exposure to the mega cap growth stocks that have been leading the market higher,” he added....
...I’m Claer Barrett, the FT’s consumer editor and presenter of our Money Clinic podcast....
...“An erosion of that [mid-20th century] thinking has been pushed by rapid consumer culture,” says Andrew Johnson, programme leader for product design at Loughborough University, one of the UK’s leading courses...
...HOLD: Synthomer (SYNT) There are some green shoots starting to emerge, but recovery is an uphill struggle, writes Jennifer Johnson....
...“It’s very clear that the Australian market wants to consume low-cost passive index products.”...
...In both cases, ETFs are hampered because, in Europe at least, they tend to be cross-border products, typically domiciled in either Ireland or Luxembourg and “passported” into other countries....
International Edition